SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-004992
Filing Date
2017-05-05
Accepted
2017-05-04 20:36:18
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20170331-10q.htm 10-Q 844242
2 EXHIBIT 10.1 ex-101xjosephhaganannualsa.htm EX-10.1 2559
3 EXHIBIT 10.2 ex-102xtimothywrightannual.htm EX-10.2 2139
4 EXHIBIT 10.3 ex-103xpaulgrintannualsala.htm EX-10.3 2400
5 EXHIBIT 31.1 ex-311x20170331.htm EX-31.1 12040
6 EXHIBIT 31.2 ex-312x20170331.htm EX-31.2 12068
7 EXHIBIT 32.1 ex-321x20170331.htm EX-32.1 11533
  Complete submission text file 0001628280-17-004992.txt   3904825

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rgls-20170331.xml EX-101.INS 725389
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20170331.xsd EX-101.SCH 30337
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20170331_cal.xml EX-101.CAL 49417
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20170331_def.xml EX-101.DEF 141104
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20170331_lab.xml EX-101.LAB 427805
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20170331_pre.xml EX-101.PRE 232012
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 17815870
SIC: 2834 Pharmaceutical Preparations